FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

430306004: Certolizumab pegol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2708529014 Certolizumab pegol (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2764885014 Certolizumab pegol en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Certolizumab pegol Is a Inflammatory bowel disease agent false Inferred relationship Existential restriction modifier
Certolizumab pegol Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Certolizumab pegol Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Certolizumab pegol Is a Gastrointestinal agent true Inferred relationship Existential restriction modifier
Certolizumab pegol Has disposition Tumor necrosis factor alpha inhibitor true Inferred relationship Existential restriction modifier
Certolizumab pegol Is a Substance with tumor necrosis factor alpha inhibitor mechanism of action true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing certolizumab pegol Has active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Certolizumab pegol 200mg powder for injection solution vial + diluent Has active ingredient False Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol therapy Direct substance True Certolizumab pegol Inferred relationship Existential restriction modifier 2
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol Has active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Product containing certolizumab pegol in parenteral dose form (medicinal product form) Has active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Product containing only certolizumab pegol in parenteral dose form (medicinal product form) Has active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Certolizumab pegol Inferred relationship Existential restriction modifier 1
Certolizumab pegol 200mg/1ml solution for injection cartridges Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection cartridges 2 cartridge Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection cartridges Has active ingredient False Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection in a dose-dispenser cartridge (UCB Pharma Ltd) 2 cartridge Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection in a dose-dispenser cartridge (UCB Pharma Ltd) Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes Has active ingredient False Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection pre-filled syringes (UCB Pharma Ltd) Has active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection pre-filled syringes (UCB Pharma Ltd) Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes 2 syringe Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection pre-filled syringes (UCB Pharma Ltd) 2 syringe Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd) Has active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd) Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Certolizumab pegol 200mg/1ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier
Cimzia 200mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd) 2 pre-filled disposable injection Has specific active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start